Valuation Update With 7 Day Price Move • Mar 10
Investor sentiment improves as stock rises 25% After last week's 25% share price gain to JP¥1,049, the stock trades at a trailing P/E ratio of 13.3x. Average trailing P/E is 17x in the Software industry in Japan. Total returns to shareholders of 69% over the past three years. Reported Earnings • Feb 16
Third quarter 2026 earnings released: EPS: JP¥8.42 (vs JP¥5.26 in 3Q 2025) Third quarter 2026 results: EPS: JP¥8.42 (up from JP¥5.26 in 3Q 2025). Revenue: JP¥1.43b (up 18% from 3Q 2025). Net income: JP¥45.0m (up 61% from 3Q 2025). Profit margin: 3.1% (up from 2.3% in 3Q 2025). Over the last 3 years on average, earnings per share has increased by 105% per year but the company’s share price has only increased by 14% per year, which means it is significantly lagging earnings growth. Bekanntmachung • Dec 02
Fuva Brain Limited to Report Q3, 2026 Results on Feb 13, 2026 Fuva Brain Limited announced that they will report Q3, 2026 results on Feb 13, 2026 New Risk • Nov 23
New major risk - Earnings quality The company has a high level of non-cash earnings. Accrual ratio: 41% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.3% average weekly change). High level of non-cash earnings (41% accrual ratio). Minor Risk Market cap is less than US$100m (JP¥4.28b market cap, or US$27.3m). Valuation Update With 7 Day Price Move • Nov 14
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to JP¥850, the stock trades at a trailing P/E ratio of 12.7x. Average trailing P/E is 22x in the Software industry in Japan. Total returns to shareholders of 25% over the past three years. Bekanntmachung • Sep 01
Fuva Brain Limited to Report Q2, 2026 Results on Nov 14, 2025 Fuva Brain Limited announced that they will report Q2, 2026 results on Nov 14, 2025 Reported Earnings • Aug 16
First quarter 2026 earnings released: EPS: JP¥45.84 (vs JP¥0.57 loss in 1Q 2025) First quarter 2026 results: EPS: JP¥45.84 (up from JP¥0.57 loss in 1Q 2025). Revenue: JP¥1.30b (up 36% from 1Q 2025). Net income: JP¥245.0m (up JP¥248.0m from 1Q 2025). Profit margin: 19% (up from net loss in 1Q 2025). Over the last 3 years on average, earnings per share has increased by 83% per year but the company’s share price has only increased by 5% per year, which means it is significantly lagging earnings growth. Reported Earnings • Jun 29
Full year 2025 earnings released: EPS: JP¥20.66 (vs JP¥5.16 in FY 2024) Full year 2025 results: EPS: JP¥20.66 (up from JP¥5.16 in FY 2024). Revenue: JP¥4.37b (up 42% from FY 2024). Net income: JP¥109.0m (up 304% from FY 2024). Profit margin: 2.5% (up from 0.9% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Jun 16
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to JP¥1,004, the stock trades at a trailing P/E ratio of 49.2x. Average trailing P/E is 21x in the Software industry in Japan. Total returns to shareholders of 34% over the past three years. Bekanntmachung • Jun 10
Fuva Brain Limited announced that it has received ¥14.963 million in funding from Modern Path LLC On June 9, 2025, Fuva Brain Limited closed the transaction. Bekanntmachung • May 31
Fuva Brain Limited to Report Q1, 2026 Results on Aug 14, 2025 Fuva Brain Limited announced that they will report Q1, 2026 results on Aug 14, 2025 Valuation Update With 7 Day Price Move • May 27
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to JP¥864, the stock trades at a trailing P/E ratio of 44.4x. Average trailing P/E is 20x in the Software industry in Japan. Total returns to shareholders of 14% over the past three years. New Risk • May 25
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Japanese stocks, typically moving 9.4% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.4% average weekly change). High level of non-cash earnings (45% accrual ratio). Minor Risk Market cap is less than US$100m (JP¥4.32b market cap, or US$30.3m). Reported Earnings • May 21
Full year 2025 earnings released: EPS: JP¥20.66 (vs JP¥5.16 in FY 2024) Full year 2025 results: EPS: JP¥20.66 (up from JP¥5.16 in FY 2024). Revenue: JP¥4.37b (up 42% from FY 2024). Net income: JP¥109.0m (up 304% from FY 2024). Profit margin: 2.5% (up from 0.9% in FY 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth. Bekanntmachung • May 15
Fuva Brain Limited, Annual General Meeting, Jun 24, 2025 Fuva Brain Limited, Annual General Meeting, Jun 24, 2025. New Risk • Apr 07
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 6.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.6% average weekly change). Market cap is less than US$100m (JP¥2.73b market cap, or US$18.7m). Valuation Update With 7 Day Price Move • Apr 04
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to JP¥582, the stock trades at a trailing P/E ratio of 39.8x. Average trailing P/E is 19x in the Software industry in Japan. Total loss to shareholders of 19% over the past three years. Bekanntmachung • Mar 04
Fuva Brain Limited to Report Fiscal Year 2025 Results on May 15, 2025 Fuva Brain Limited announced that they will report fiscal year 2025 results at 3:00 PM, Tokyo Standard Time on May 15, 2025 Reported Earnings • Feb 16
Third quarter 2025 earnings released: EPS: JP¥5.26 (vs JP¥3.27 loss in 3Q 2024) Third quarter 2025 results: EPS: JP¥5.26 (up from JP¥3.27 loss in 3Q 2024). Revenue: JP¥1.21b (up 68% from 3Q 2024). Net income: JP¥28.0m (up JP¥45.0m from 3Q 2024). Profit margin: 2.3% (up from net loss in 3Q 2024). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 34% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth. Bekanntmachung • Nov 30
Fuva Brain Limited to Report Q3, 2025 Results on Feb 14, 2025 Fuva Brain Limited announced that they will report Q3, 2025 results on Feb 14, 2025 Bekanntmachung • Aug 27
Fuva Brain Limited to Report Q2, 2025 Results on Nov 14, 2024 Fuva Brain Limited announced that they will report Q2, 2025 results on Nov 14, 2024 Reported Earnings • Aug 11
First quarter 2025 earnings released: JP¥0.57 loss per share (vs JP¥0.56 profit in 1Q 2024) First quarter 2025 results: JP¥0.57 loss per share (down from JP¥0.56 profit in 1Q 2024). Revenue: JP¥956.0m (up 29% from 1Q 2024). Net loss: JP¥3.00m (down 200% from profit in 1Q 2024). New Risk • Aug 02
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Japanese stocks, typically moving 7.4% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (7.4% average weekly change). Minor Risk Market cap is less than US$100m (JP¥5.44b market cap, or US$36.6m). Reported Earnings • May 21
Full year 2024 earnings released: EPS: JP¥5.16 (vs JP¥4.87 in FY 2023) Full year 2024 results: EPS: JP¥5.16 (up from JP¥4.87 in FY 2023). Revenue: JP¥3.08b (up 32% from FY 2023). Net income: JP¥27.0m (up 3.8% from FY 2023). Profit margin: 0.9% (down from 1.1% in FY 2023). The decrease in margin was driven by higher expenses. Bekanntmachung • May 17
Fuva Brain Limited, Annual General Meeting, Jun 25, 2024 Fuva Brain Limited, Annual General Meeting, Jun 25, 2024. Bekanntmachung • Apr 07
Fuva Brain Limited to Report Fiscal Year 2024 Results on May 15, 2024 Fuva Brain Limited announced that they will report fiscal year 2024 results on May 15, 2024 Reported Earnings • Feb 17
Third quarter 2024 earnings released: JP¥3.27 loss per share (vs JP¥2.44 loss in 3Q 2023) Third quarter 2024 results: JP¥3.27 loss per share (further deteriorated from JP¥2.44 loss in 3Q 2023). Revenue: JP¥719.0m (up 42% from 3Q 2023). Net loss: JP¥17.0m (loss widened 31% from 3Q 2023). Bekanntmachung • Nov 29
Fuva Brain Limited to Report Q3, 2024 Results on Feb 14, 2024 Fuva Brain Limited announced that they will report Q3, 2024 results on Feb 14, 2024 Reported Earnings • Nov 19
Second quarter 2024 earnings released: JP¥4.04 loss per share (vs JP¥5.06 profit in 2Q 2023) Second quarter 2024 results: JP¥4.04 loss per share (down from JP¥5.06 profit in 2Q 2023). Revenue: JP¥726.0m (up 30% from 2Q 2023). Net loss: JP¥21.0m (down 178% from profit in 2Q 2023). Bekanntmachung • Sep 03
Fuva Brain Limited to Report Q2, 2024 Results on Nov 14, 2023 Fuva Brain Limited announced that they will report Q2, 2024 results on Nov 14, 2023 Reported Earnings • Aug 13
First quarter 2024 earnings released: EPS: JP¥0.56 (vs JP¥1.31 in 1Q 2023) First quarter 2024 results: EPS: JP¥0.56 (down from JP¥1.31 in 1Q 2023). Revenue: JP¥742.0m (up 33% from 1Q 2023). Net income: JP¥3.00m (down 57% from 1Q 2023). Profit margin: 0.4% (down from 1.3% in 1Q 2023). The decrease in margin was driven by higher expenses. Bekanntmachung • Jun 03
Fuva Brain Limited to Report Q1, 2024 Results on Aug 10, 2023 Fuva Brain Limited announced that they will report Q1, 2024 results on Aug 10, 2023 Reported Earnings • May 17
Full year 2023 earnings released: EPS: JP¥4.87 (vs JP¥5.44 loss in FY 2022) Full year 2023 results: EPS: JP¥4.87 (up from JP¥5.44 loss in FY 2022). Revenue: JP¥2.34b (up 39% from FY 2022). Net income: JP¥26.0m (up JP¥55.0m from FY 2022). Profit margin: 1.1% (up from net loss in FY 2022). The move to profitability was driven by higher revenue. Valuation Update With 7 Day Price Move • May 17
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to JP¥699, the stock trades at a trailing P/E ratio of 56.5x. Average trailing P/E is 22x in the Software industry in Japan. Total loss to shareholders of 59% over the past three years. Bekanntmachung • May 16
Fuva Brain Limited (TSE:3927) announces an Equity Buyback for 170,000 shares, representing 3.18% for ¥100 million. Fuva Brain Limited (TSE:3927) announces a share repurchase program. Under the program, the company will repurchase up to 170,000 shares, representing 3.18% of its total shares outstanding (excluding treasury shares), for a total of ¥100 million. The purpose of the program is to enhance shareholder returns, improve capital efficiency and flexible implementation in response to changes in the business environment. The repurchase program is valid till November 15, 2023. As of March 31, 2023, the company had 5,338,838 shares outstanding (excluding treasury shares) and had 261,362 shares in treasury. Reported Earnings • Feb 16
Third quarter 2023 earnings released: JP¥2.44 loss per share (vs JP¥8.43 profit in 3Q 2022) Third quarter 2023 results: JP¥2.44 loss per share (down from JP¥8.43 profit in 3Q 2022). Revenue: JP¥507.0m (down 3.8% from 3Q 2022). Net loss: JP¥13.0m (down 129% from profit in 3Q 2022). Reported Earnings • Nov 17
Second quarter 2023 earnings released: EPS: JP¥5.06 (vs JP¥8.43 in 2Q 2022) Second quarter 2023 results: EPS: JP¥5.06 (down from JP¥8.43 in 2Q 2022). Revenue: JP¥559.0m (up 6.1% from 2Q 2022). Net income: JP¥27.0m (down 40% from 2Q 2022). Profit margin: 4.8% (down from 8.5% in 2Q 2022). Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Outside Director Takuya Uemura was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Bekanntmachung • Sep 10
Fuva Brain Limited to Report Q2, 2023 Results on Nov 14, 2022 Fuva Brain Limited announced that they will report Q2, 2023 results on Nov 14, 2022 Bekanntmachung • Jun 03
Fuva Brain Limited to Report Q1, 2023 Results on Aug 12, 2022 Fuva Brain Limited announced that they will report Q1, 2023 results on Aug 12, 2022 Bekanntmachung • May 15
Fuva Brain Limited, Annual General Meeting, Jun 27, 2022 Fuva Brain Limited, Annual General Meeting, Jun 27, 2022. Board Change • Apr 27
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Outside Director Takuya Uemura was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Bekanntmachung • Apr 08
Fuva Brain Limited to Report Fiscal Year 2022 Results on May 13, 2022 Fuva Brain Limited announced that they will report fiscal year 2022 results on May 13, 2022 Bekanntmachung • Feb 16
Fuva Brain Limited announced that it has received ¥0.5 million in funding On February 15, 2022, Fuva Brain Limited closed the transaction. Bekanntmachung • Feb 02
Fuva Brain Limited announced that it expects to receive ¥0.5 million in funding Ahkun Co., Ltd. announced a private placement to issue 500 12th stock acquisition right securities at issue price of ¥100 per stock acquisition right for gross proceeds of ¥50,000 on January 31, 2022. The transaction will include participation from Nexpander Japan LLC for 500 stock acquisition rights. The transaction is expected to close on February 15, 2022. The transaction is through third party allotment. The stock acquisition right is convertible into 50,000 common stock of the company at an exercise price of ¥588 per share for gross proceeds of ¥29,400,000. The exercise period starts from the fiscal year ending March 2023 to the fiscal year ending March 2028. The company will pay approximate amount of deductions of JPY 26,450,000 including issuance costs of JPY 3,000,000. The transaction has been approved by the board of directors of the company. Reported Earnings • May 17
Full year 2021 earnings released: JP¥34.14 loss per share (vs JP¥16.13 loss in FY 2020) The company reported a soft full year result with increased losses and weaker control over costs, although revenues improved. Full year 2021 results: Revenue: JP¥1.08b (up 3.4% from FY 2020). Net loss: JP¥174.0m (loss widened 156% from FY 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 83 percentage points per year, which is a significant difference in performance. Bekanntmachung • Mar 04
Fuva Brain Limited to Report Fiscal Year 2021 Results on May 14, 2021 Fuva Brain Limited announced that they will report fiscal year 2021 results on May 14, 2021 Is New 90 Day High Low • Feb 15
New 90-day low: JP¥873 The company is down 18% from its price of JP¥1,059 on 17 November 2020. The Japanese market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Software industry, which is up 5.0% over the same period. Reported Earnings • Feb 14
Third quarter 2021 earnings released: JP¥6.27 loss per share (vs JP¥0.95 profit in 3Q 2020) The company reported a poor third quarter result with weaker earnings, revenues and control over costs. Third quarter 2021 results: Revenue: JP¥257.0m (down 13% from 3Q 2020). Net loss: JP¥33.0m (down JP¥37.0m from profit in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 2% per year whereas the company’s share price has increased by 1% per year. Is New 90 Day High Low • Dec 22
New 90-day low: JP¥899 The company is down 26% from its price of JP¥1,212 on 23 September 2020. The Japanese market is up 8.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Software industry, which is up 2.0% over the same period. Is New 90 Day High Low • Dec 07
New 90-day low: JP¥943 The company is down 16% from its price of JP¥1,128 on 08 September 2020. The Japanese market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Software industry, which is up 6.0% over the same period. Bekanntmachung • Sep 04
Fuva Brain Limited to Report Q2, 2021 Results on Nov 12, 2020 Fuva Brain Limited announced that they will report Q2, 2021 results on Nov 12, 2020 
